The goal of this observational study is to evaluate the feasibility of a systematic screening protocol for Obstructive Sleep Apnea (OSA) during preoperative anesthesia consultations in adults aged 50 and older undergoing elective surgery. The main questions it aims to answer are: * Does the systematic screening protocol increase the proportion of patients identified as being at high risk for OSA compared to standard care? * What is the impact of systematic screening on postoperative outcomes, including complications, length of stay, and mortality? Researchers will compare standard care practices (before implementation) to the systematic screening protocol (after implementation) to determine the effect on OSA detection rates and clinical outcomes. Participants will: * Complete the STOP-BANG questionnaire during their anesthesia consultation. * (Optional) Have a facial photograph taken to analyze morphometric characteristics that may correlate with OSA risk. * Be referred for further diagnostic testing if identified as high-risk for OSA.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
proportion of participants in whom the risk of OSA (Obstructive Sleep Apnea Syndrome) was detected in the control group before versus the group after
Timeframe: From enrollment to the end of treatment at 7 months